Topic

Autoimmune disease Steady

378 applications whose title mentions it. Its share of new filings over the last two years is -33% below the four years before.

Allowance rate

47%

−29 pts vs the USPTO 337 decided

Months to first action

19.9 mo

+1.3 vs the USPTO

Applications

378.0

in the record

Allowed

157.0

180 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K156 apps

C07K90 apps

G01N50 apps

C07D35 apps

C12Q13 apps

C12N11 apps

Art units

164483 apps

164733 apps

164628 apps

164116 apps

OPAP15 apps

164512 apps

Examiners

Who examines it, and how it fares with each

Gerald R Ewoldt29 apps

17%

Docket Central15 apps

n/a

Chun Wu Dahle9 apps

33%

Phuong N Huynh9 apps

22%

Prema Maria Mertz9 apps

78%

Marianne Dibrino8 apps

43%

Jon McClelland Lockard7 apps

86%

Bridget E Bunner6 apps

40%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

Hoffmann-La Roche Inc.22 apps

48%

NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT17 apps

35%

NOVARTIS AG7 apps

33%

MEDIMMUNE LIMITED6 apps

50%

CAMBRIDGE ENTERPRISE LIMITED5 apps

40%

Enzo Biochem, Inc.5 apps

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

GENENTECH, INC.27 apps

46%

Medlen & Carroll, LLP12 apps

75%

pH IP Law10 apps

50%

GlaxoSmithKline8 apps

13%

Kilpatrick Townsend & Stockton LLP - West Coast7 apps

33%

IMMUNOMEDICS, INC. c/o Gilead Sciences, Inc.6 apps

67%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19626858	COMPOSITIONS AND METHODS USEFUL IN THE TREATMENT OF AUTOIMMUNE DISEASE	2026-09-22	Pending	0	0	n/a
19624034	TREATMENT REGIMENS FOR AUTOIMMUNE DISEASE WITH CD19-TARGETING ENGINEERED IMMUNE CEL…	2026-09-14	Pending	0	0	n/a
19622611	TREATMENT OF AUTOIMMUNE DISEASE BY CO-EXPRESSION OF CD19-CAR AND BCMA-CAR	2026-09-09	Pending	0	0	n/a
15812394	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15361292	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15697477	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15408125	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15786154	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15865679	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15176218	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in